The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Sacroiliac Joint Fusion Global Market Report 2024, the sacroiliac joint fusion market is expected to show promising growth in the forecast period.

Market Overview

• Recent Growth: The sacroiliac joint fusion market has seen substantial growth, expanding from $0.57 billion in 2023 to $0.68 billion in 2024, marking a compound annual growth rate (CAGR) of 17.8%.
• Historic Growth Drivers: This growth is driven by increasing chronic diseases, the rise in joint pain prevalence, improved surgical techniques, demand for safer joint fusion systems, and expanded reimbursement coverage for minimally invasive procedures.

Future Market Projections

• Forecast Growth: The market is projected to reach $1.32 billion by 2028, with a CAGR of 18.1%.
• Forecast Drivers: Expected growth factors include the rising prevalence of lower back pain, increasing incidence of sacroiliitis, demand for less painful procedures, preference for minimally invasive surgeries, and a growing geriatric population.

Key Trends

• Innovative Technologies: Significant investments are being made in new technologies and procedures.
• Advanced Materials: Adoption of new materials and 3D-printed titanium implants.
• Enhanced Diagnostics: Improvements in diagnostic capabilities for sacroiliac joint disorders.
• Healthcare Infrastructure: Advancements in healthcare infrastructure support the market’s growth.

View More On The Sacroiliac Joint Fusion Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sacroiliac-joint-fusion-global-market-report

Rising Prevalence of Lower Back and Sacroiliac Joint Pain

• Prevalence Impact: The increasing prevalence of lower back pain is a major driver for the sacroiliac joint fusion market.
  • Conditions: Lower back pain, often caused by stress, sedentary lifestyles, obesity, and poor diet, can vary from a dull ache to sharp pain.
  • Market Demand: Sacroiliac joint fusion helps stabilize the joint, reducing pain and improving quality of life.
  • Statistics: As reported by the National Center for Biotechnology Information, low back pain affected 619 million people globally in 2020, expected to rise to 843 million by 2050.

Leading Companies

• Key Players: Major companies in the market include Medtronic Plc, Zimmer Biomet Holdings Inc., Integra LifeSciences, NuVasive Inc., and SI-BONE Inc.
  • Innovations: Companies are developing advanced implants, such as the granite implant system for sacroiliac joint fusion.
  • Example: In May 2024, SI-BONE Inc. launched the iFuse Bedrock Granite Implant System, which received Breakthrough Device Designation from the FDA.

Strategic Acquisitions

• Nevro Corp’s Move: In November 2023, Nevro Corp acquired Vyrsa Technologies for $75 million.
  • Purpose: This acquisition aims to enhance Nevro’s offerings in minimally invasive treatments for chronic sacroiliac joint pain.
  • Focus: Vyrsa Technologies specializes in minimally invasive solutions, complementing Nevro’s strategic goals.

Market Segmentation

• By Product: Implants, Accessories, Injections, Diagnosis, Treatment, RF Ablation.
• By Indication Type: Degenerative Sacroiliitis, Sacral Disruption, Trauma.
• By Approach: Dorsal, Anterior.
• By End-user: Hospitals, Ambulatory Surgical Centers, Other End Users.

Regional Insights

• Current Leader: North America was the largest market region in 2023.
• Future Growth: Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The sacroiliac joint fusion market is poised for continued growth, driven by advancements in technology, increasing prevalence of lower back pain, and strategic expansions by major players. The focus on minimally invasive procedures and innovative implants will shape the future of the market.

Request A Sample Of The Global Sacroiliac Joint Fusion Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15921&type=smp